KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $1.83.

  • West Pharmaceutical Services' EPS (Basic) rose 223.46% to $1.83 in Q4 2025 from the same period last year, while for Dec 2025 it was $6.83, marking a year-over-year increase of 118.52%. This contributed to the annual value of $6.83 for FY2025, which is 118.52% up from last year.
  • As of Q4 2025, West Pharmaceutical Services' EPS (Basic) stood at $1.83, which was up 223.46% from $1.94 recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' EPS (Basic) peaked at $2.53 during Q2 2021, and registered a low of $1.24 during Q1 2025.
  • In the last 5 years, West Pharmaceutical Services' EPS (Basic) had a median value of $1.88 in 2023 and averaged $1.92.
  • Its EPS (Basic) has fluctuated over the past 5 years, first soared by 11351.35% in 2021, then plummeted by 3164.56% in 2022.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' EPS (Basic) stood at $1.94 in 2021, then decreased by 28.87% to $1.38 in 2022, then skyrocketed by 34.06% to $1.85 in 2023, then decreased by 3.24% to $1.79 in 2024, then rose by 2.23% to $1.83 in 2025.
  • Its EPS (Basic) stands at $1.83 for Q4 2025, versus $1.94 for Q3 2025 and $1.82 for Q2 2025.